President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Medicare said it will negotiate prices for its 15 highest spending drugs, mainly for cancer, autoimmune disorders, and chronic conditions.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...